Issue link: https://www.e-digitaleditions.com/i/1463386
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 20 April 2022 Inhalation ISSUE FOCUS Instruments This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Semi- or fully automated testing systems Not only can you accurately control test variables such as air flow, firing force, speed and distance for dose wasting and collection, but each part of your semi- or fully automated testing system provides the traceable data needed for quality and compliance. Your 21 CFR Part 11 compliant data capture, storage and retrieval is available through our user friendly Relovex ® soft- ware. And your testing system can be installed as a standalone unit or integrated into Astech's full range of automated testing systems. Astech Projects UK: +44 1928 571797 www.astechprojects.co.uk pMDI Collection System e Kinaero Cx pMDI Collection System ensures reliable, repeatable results for delivered dose unifor- mity (DDU) and aerodynamic particle size distribu- tion (APSD) testing by automating shaking, actuation and dose/sample collection using proven Vereo ® Actuator technology. e system offers the flexibility to run both DDU and APSD measurements for test- ing pMDI devices. To automate the whole workflow, users can run the Cx alongside the Kinaero™ pMDI Fire-Down System for through-life testing, utilizing a powerful common software platform that offers all tools for full regulatory compliance (21 CFR Part 11). Proveris Scientific Corporation US: +1 508 460-8822 contactus@proveris.com www.proveris.com Products for nasal drug testing Recently, nasal drug products have been a subject of intense research and development (R&D). Sev- eral new products launched recently are designed to streamline and simplify your nasal drug R&D. Our new products range from manual collection method- ologies to more advanced automated techniques and technologies via Vertus integration. ey can maxi- mize reproducibility and efficiency while minimiz- ing health and safety risks commonly associated with high volume testing. Contact MSP for more informa- tion on nasal drug product testing. MSP, a Division of TSI US: +1 651 417-1440 www.TSI.com